Azithromycin in the treatment of COVID-19: a review

D Echeverría-Esnal, C Martin-Ontiyuelo… - Expert review of anti …, 2021 - Taylor & Francis
Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis

B Panizzutti, D Skvarc, S Lin, S Croce… - International Journal of …, 2023 - mdpi.com
Minocycline has anti-inflammatory, antioxidant, and anti-apoptotic properties that explain the
renewed interest in its use as an adjunctive treatment for psychiatric and neurological …

Repurposing known drugs as covalent and non-covalent inhibitors of the SARS-CoV-2 papain-like protease

P Delre, F Caporuscio, M Saviano… - Frontiers in …, 2020 - frontiersin.org
In the absence of an approved vaccine, develo** effective severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) antivirals is essential to tackle the current pandemic …

Pleiotropic effects of tetracyclines in the management of COVID-19: emerging perspectives

HM Al-Kuraishy, AI Al-Gareeb, M Alqarni… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a global infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 15% of severe …

Using informative features in machine learning based method for COVID-19 drug repurposing

R Aghdam, M Habibi, G Taheri - Journal of cheminformatics, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by a novel virus named Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This virus induced a large …

SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis

Q Zheng, R Lin, Y Chen, Q Lv, J Zhang, J Zhai… - Frontiers in …, 2022 - frontiersin.org
Background The coronavirus disease (COVID-19) is a pandemic disease that threatens
worldwide public health, and rheumatoid arthritis (RA) is the most common autoimmune …

Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a sco** review

A Rezaei, A Moqadami, M Khalaj-Kondori - … -Schmiedeberg's Archives of …, 2024 - Springer
Minocycline is an FDA-approved secondary-generation tetracycline antibiotic. It is a
synthetic antibiotic having many biological effects, such as antioxidant, anti-inflammatory …

Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress

MJ Hossain, SMA Rahman - Expert Review of Anti-Infective …, 2021 - Taylor & Francis
Introduction The pathogenic and highly transmissible etiological agent, SARS-CoV-2, has
caused a serious threat COVID-19 pandemic. WHO has declared the epidemic a public …

[HTML][HTML] Integrating heterogeneous data to facilitate COVID-19 drug repurposing

LP Santamaría, MD Uzquiano, EU Carro… - Drug Discovery …, 2022 - Elsevier
In the COVID-19 pandemic, drug repositioning has presented itself as an alternative to the
time-consuming process of generating new drugs. This review describes a drug repurposing …

[PDF][PDF] Пандемия COVID-19: актуальные вызовы времени, а также новейшие данные к вопросу рационального выбора психофармакотерапии у пациентов с …

НН Петрова, ПВ Морозов, АВ Маркин… - Психиатрия и …, 2020 - academia.edu
Резюме Бушующая в последний год во всем мире пандемия COVID-19 привела к
резкому ухудшению психического здоровья и психологического благополучия всей …